Crohn disease: Pathophysiology, diagnosis, and treatment

Radiologic Technology

Volumn 85, Issue 3, 2014, Pages 297-316

  Mazal, Jonathan ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT;

ABDOMINAL SURGERY; ANAMNESIS; ARTICLE; CROHN DISEASE; DIAGNOSTIC IMAGING; HUMAN; METHODOLOGY; PHYSICAL EXAMINATION;

ANTI-INFLAMMATORY AGENTS; CROHN DISEASE; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION;

EID: 84894035737     PISSN: 00338397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2004;369(9573):1641-1657. doi:10.1016/S0140-6736(07)60751-X
2. Crawford JM. The gastrointestinal tract. In: Contran RS, Kumar V, Robbins SL. Robbins Basic Pathology. 7th ed. Philidelphia, PA: Saunders; 2003:572-575
3. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369(9573):1627-1640. doi:10.1016/S0140-6736(07)60750-8
4. Huang CS, Saubermann LJ, Farraye FA. Inflammatory bowel disease. In: Andreoli TE, Carpenter CCJ, Griggs RC, Benjamin IJ, eds. Cecil Essentials of Medicine. 7th ed. Philadelphia, PA: Saunders Elsevier; 2007:406-414
5. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504-1517. doi:10.1053/j.gast ro.2004.01.063
6. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40(8):955-962. doi:10.1038/ng.175
7. Marks DJ, Harbord MW, MacAllister R, et al. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet. 2006;367(9511):668-678. doi:10.1016/S0140-6736(06)68265-2
8. Zheng JJ, Zhu XS, Huangfu Z, Gao ZX, Guo ZR, Wang Z. Crohn's disease in mainland China: a systematic analysis of 50 years of research. Chin J Dig Dis. 2005;6(4):175-181. doi:10.1111/j.1443-9573.2005.00227.x
9. Huether SE. Structure and function of the digestive system. In: McCance KL, Huether SE. Pathophysiology: The Biologic Basis for Disease in Adults and Children. 5th ed. St Louis, MO: Elsevier Mosby; 2006:1404-1407
10. Crawford JM. The gastrointestinal tract. In: Contran RS, Kumar V, Robbins SL. Robbins Basic Pathology. 7th ed. Philadelphia, PA: Saunders; 2003:572-575
11. Kurata JH, Kantor-Fish S, Frankl H, Godby P, Vadheim CM. Crohn's disease among ethnic groups in a large health maintenance organization. Gasteroenterol. 1992;102(6):1940-1948
12. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16(1):51-60. doi:10.1046/j.1365-2036.2002.01140.x
13. McQuaid KR. Alimentary tract. In: Tierney LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis & Treatment. 45th ed. McGraw Hill; 2006:620-631
14. Seidel HM, Ball JW, Dains JE, Benedict GW. Mosby's Guide to Physical Examination. 6th ed. St Louis, MO: Mosby; 2006: 12-31, 526-543
15. Pagana KD, Pagana TJ. Mosby's Manual of Diagnostic and Laboratory Tests. 3rd ed. St Louis, MO: Mosby Elsevier; 2006:199-201, 232-235, 537-544
16. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55(3):426-431. doi:10.1136/gut.2005.069476
17. MacKalski BA, Bernstein CN. New diagnostic imaging tools for inflammatory bowel disease. Gut. 2006;55(5):733-741. doi:10.1136/gut.2005.076612
18. Dionisio PM, Suryakanth RG, Leighton JA, et al. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn's disease: a meta-analysis. Amer J Gastroenterol. 2010;105(6):1240-1248. doi:10.1038/ajg.2009.713
19. Triester SL, Leighton JA, Leontiadis GI, et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn's disease. Amer J Gastroenterol. 2006;101(5):954-964. doi:10.1111/j.1572-0241.2006.00506.x
20. Howland RA, Mycek MJ. Lippincott's Illustrated Reviews: Pharmacology. 3rd ed. Baltimore, MD: Lippincott Williams & Wilkins; 2006
21. Langmead L, Rampton D. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther. 2006;23(3):341-349. doi:10.1111/j.1365-2036.2006.02761.x
22. Hedin C, Whelan K, Lindsay J. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc. 2007;66(3):307-315. doi:10.1017/S0029665107005563
23. Spanier J, Howden C, Jones M. A systematic review of alternative therapies in the irritable bowel syndrome. Arch Intern Med. 2003;163(3):265-274. doi:10.1001/archinte.163.3.265
24. Zijlstra F, van den Berg-de Lange I, Huygen FJ, Klein J. Antiinflammatory actions of acupuncture. Mediators Inflamm. 2003;12(2):59-69. doi:10.1080/0962935031000114943
25. Latella G, Sferra R, Vetuschi A, et al. Prevention of colonic fibrosis by Boswelia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid. Euro J Clin Invest. 2008;38(6):410-420. doi:10.1111/j.1365-2362.2008.01955.x
26. Massa F, Storr M, Lutz B. The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract. J Mol Med (Berl). 2005;83(12):944-954
27. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol. 2004;18(3):481-496. doi:10.1016/j.bpg.2003.12.003
28. Persoons P, Vermiere S, Demyttenaere K, et al. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther. 2005;22(2):101-110. doi:10.1111/j.1365-2036.2005.02535.x
29. Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007;22(11):1748-1753. doi:10.1111/j.1440-1746.2006.04820.x
30. R Shoda, K Matsueda, S Yamato, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996;63(5):741-745